Pliant Therapeutics Inc
F:9PT
Pliant Therapeutics Inc
F:9PT
Price:
0.8995
EUR
-0.61%
Market Closed
Market Cap:
€53.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
Aguia Resources Ltd
F:5N91
|
AU |
|
Barrick Mining Corp
F:ABR0
|
CA |
|
Gemfields Group Ltd
LSE:GEM
|
GG |
|
Stratasys Ltd
NASDAQ:SSYS
|
US |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
Citra Marga Nusaphala Persada Tbk PT
IDX:CMNP
|
ID |
|
4DMedical Ltd
ASX:4DX
|
AU |
|
Intraco Ltd
SGX:I06
|
SG |
|
S
|
Suncor Energy Inc (Canada)
DUS:SM3
|
CA |
|
P
|
Pfizer Inc
BMV:PFE
|
US |
|
Aena SME SA
OTC:ANNSF
|
ES |
|
A
|
AlTi Global, Inc
NASDAQ:ALTI
|
US |
|
Double Standard Inc
TSE:3925
|
JP |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Pliant Therapeutics Inc (9PT) under the Base Case is hidden
EUR.
Compared with the current market price of 0.8995 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
9PT Multiples-Based Value
LOCKED